. Author manuscript; available in PMC: 2023 Feb 11.

Published in final edited form as: Cancer Epidemiol. 2020 Apr 1;66:101710. doi: 10.1016/j.canep.2020.101710

Table 2.

Multivariable-adjusted analysis for preexisting type 2 diabetes mellitus status in relation to mortality among 9221 Medicaid-insured women with breast cancer from 2004-2016 in New York State.

Variables	Type 2 Diabetes Mellitus Status HR (95 % CI) ^a
Variables	No	Yes
All-cause Mortality	Referent	1.40 (1.21, 1.63)
Cancer Mortality	Referent	1.24 (1.04, 1.47)
Cardiovascular Mortality	Referent	2.46 (1.54, 3.90)

Note: Estimated menopausal status defined as: Premenopausal < 50 years of age and Postmenopausal ≥50 years of age.

Abbreviations: HR, Hazard Ratio 95 % CI, 95 % confidence interval.

Adjusted for race/ethnicity, estimated menopausal status, age at breast cancer diagnosis, breast cancer date of diagnosis, marital status at diagnosis, obesity, coronary heart disease, stroke, chronic kidney disease, molecular subtype, chemotherapy, surgery, hormone therapy, SEER Summary Staging.